Theravance Biopharma, Inc.

TBPH · Nasdaq · SIC 2834: Pharmaceutical Preparations
239
SEC Filings

Business Summary

PART I Overview Theravance Biopharma, Inc. (we, our, Theravance Biopharma or the Company) is a biopharmaceutical company primarily focused on the development and commercialization of medicines. Our focus is to deliver medicines that make a difference in peoples lives. In pursuit of our purpose, we leverage decades of expertise, which has led to the development of the United States (US) Food and Drug Administration (the FDA) approved YUPELRI (revefenacin) inhalation solution indicated for the mai...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTBPHdiscussed_in_filing Cybersecurity
topic_mentionTBPHdiscussed_in_filing Trusted Computing
topic_mentionTBPHdiscussed_in_filing Blockchain & Crypto
topic_mentionTBPHdiscussed_in_filing Regulation
topic_mentionTBPHdiscussed_in_filing Healthcare & Bio
topic_mentionTBPHdiscussed_in_filing Sovereign & Government
topic_mentionTBPHdiscussed_in_filing Cybersecurity
topic_mentionTBPHdiscussed_in_filing Trusted Computing
topic_mentionTBPHdiscussed_in_filing Blockchain & Crypto
topic_mentionTBPHdiscussed_in_filing Regulation
topic_mentionTBPHdiscussed_in_filing Healthcare & Bio
topic_mentionTBPHdiscussed_in_filing Sovereign & Government
topic_mentionTBPHdiscussed_in_filing Cybersecurity
topic_mentionTBPHdiscussed_in_filing Trusted Computing
topic_mentionTBPHdiscussed_in_filing Blockchain & Crypto
topic_mentionTBPHdiscussed_in_filing Regulation
topic_mentionTBPHdiscussed_in_filing Healthcare & Bio
topic_mentionTBPHdiscussed_in_filing Sovereign & Government
topic_mentionTBPHdiscussed_in_filing Cybersecurity
topic_mentionTBPHdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001104659-26-033077EDGAR69K words
2025-03-072024-12-310001558370-25-002447EDGAR—
2024-03-012023-12-310001558370-24-002267EDGAR—
2023-03-012022-12-310001558370-23-002595EDGAR—
2022-02-282021-12-310001558370-22-002373EDGAR—
2021-02-262020-12-310001558370-21-002006EDGAR—
2020-02-272019-12-310001558370-20-001644EDGAR—
2019-02-282018-12-310001558370-19-001346EDGAR—
2018-02-282017-12-310001047469-18-001160EDGAR—
2017-03-012016-12-310001047469-17-001086EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001104659-25-110382EDGAR46K words
2025-08-132025-06-300001558370-25-011408EDGAR—
2025-05-122025-03-310001558370-25-007398EDGAR—
2024-11-142024-09-300001558370-24-015602EDGAR—
2024-08-082024-06-300001558370-24-011636EDGAR—
2024-05-152024-03-310001558370-24-008201EDGAR—
2023-11-092023-09-300001558370-23-018612EDGAR—
2023-08-092023-06-300001558370-23-014070EDGAR—
2023-05-102023-03-310001558370-23-008951EDGAR—
2022-11-092022-09-300001558370-22-017048EDGAR—
2022-08-082022-06-300001558370-22-012666EDGAR—
2022-05-062022-03-310001558370-22-007651EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001104659-26-036870EDGAR1K words
2026-03-190001104659-26-031795EDGAR—
2026-03-030001104659-26-022572EDGAR—
2026-01-120001104659-26-002726EDGAR—
2025-12-080001104659-25-119032EDGAR—
2025-11-100001104659-25-109146EDGAR—
2025-08-250001104659-25-082048EDGAR—
2025-08-200001104659-25-080470EDGAR—
2025-08-120001104659-25-076837EDGAR—
2025-06-260001104659-25-062722EDGAR—

239 total filings indexed. 207 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001583107
TickerTBPH
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedCA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 079a62bf1b755d3e09ac89bf85ac40744a0b1a7b92dbbf5bc652bc5ddff0a3f4
parent: bc5359926b5e070870fece6bfdefacebc18480220b1e76d8bb21480367d27d0a
content hash: 01f29921da79fbb2190a2a13e499756c8d32cbb9d07edece051ebe11e01c4c22
signed: 2026-04-13T04:47:43.987Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf